跳至主要内容
临床试验/NCT02662439
NCT02662439暂停不适用

Role of the Bioimpedance Analysis in Guiding the Diuretic Therapy in Chronic Heart Failure - A Randomized Controlled Trial

Peter Studinger2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2016年2月最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
240
试验地点
2
主要终点
Re-hospitalization rate

研究概览

简要总结

The aim of this study is to investigate whether the objective measurement of fluid overload by bioimpedance analysis (Body Composition Monitor-BCM) in patient with acute decompensated heart failure would improve the diuretic therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with known or newly discovered chronic heart failure admitted to hospital because of the clinical signs of acut cardiac decompensation

排除标准

  • High level of fatigue (the patient cannot stand on a scale)
  • Amputated upper and/or lower limb(s)
  • The BCM analysis is not possible technically (e.g. open wounds on the limbs)
  • Severe obesity (>130 kg)
  • Patients on chronic hemodialysis or peritoneal dialysis
  • Severe fluid volume in the transcellular space
  • Patients with a unipolar pacemaker whose sensitivity threshold is very low
  • Pregnancy, lactation

结局指标

主要结局

Re-hospitalization rate

时间窗: 12 months

次要结局

  • All cause mortality(12 months)

研究者

发起方
Peter Studinger
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Peter Studinger

Assistant Professor

Semmelweis University

研究点 (2)

Loading locations...

相似试验